Clinuvel Pharmaceuticals Ltd (CLVLF) revenue by segment

CLVLFOTCAmerican Depositary ReceiptsFiscal year ends June 30Also trades as CUVL

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 9/30

$5.05−0.33 (-6.13%)

Close on Oct 19, 2026Market cap $254.66MP/E 11.0Yield –

Clinuvel Pharmaceuticals Ltd revenue by segment

Clinuvel Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.

See a number that looks wrong?